Report Library
All Reports2016 Post-Alzheimer’s Association International Conference (AAIC) Survey
October 19, 2016
We performed a 5-question survey of 20 United States and 22 European (from France, Germany, Italy, and United Kingdom) neurologists
after the 2016 Alzheimer’s Association International Conference (2016 AAIC) to gauge views on new data presented on drugs in clinical
development, including LMTX (TauRx) and PF-05212377 (Pfizer).
If you are a KOL Insight Subscriber, please access the survey from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
If you are a KOL Insight Subscriber, please access the survey from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
Indications Covered: | Alzheimer's Disease (AD) |